Cargando…

Personalized transcranial alternating current stimulation (tACS) and physical therapy to treat motor and cognitive symptoms in Parkinson's disease: A randomized cross-over trial

Abnormal cortical oscillations are markers of Parkinson's Disease (PD). Transcranial alternating current stimulation (tACS) can modulate brain oscillations and possibly impact on behaviour. Mapping of cortical activity (prevalent oscillatory frequency and topographic scalp distribution) may pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Felice, Alessandra, Castiglia, Leonora, Formaggio, Emanuela, Cattelan, Manuela, Scarpa, Bruno, Manganotti, Paolo, Tenconi, Elena, Masiero, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439208/
https://www.ncbi.nlm.nih.gov/pubmed/30921609
http://dx.doi.org/10.1016/j.nicl.2019.101768
Descripción
Sumario:Abnormal cortical oscillations are markers of Parkinson's Disease (PD). Transcranial alternating current stimulation (tACS) can modulate brain oscillations and possibly impact on behaviour. Mapping of cortical activity (prevalent oscillatory frequency and topographic scalp distribution) may provide a personalized neurotherapeutic target and guide non-invasive brain stimulation. This is a cross-over, double blinded, randomized trial. Electroencephalogram (EEG) from participants with PD referred to Specialist Clinic, University Hospital, were recorded. TACS frequency and electrode position were individually defined based on statistical comparison of EEG power spectra maps with normative data from our laboratory. Stimulation frequency was set according to the EEG band displaying higher power spectra (with beta excess on EEG map, tACS was set at 4 Hz; with theta excess, tACS was set at 30 Hz). Participants were randomized to tACS or random noise stimulation (RNS), 5 days/week for 2-weeks followed by ad hoc physical therapy. EEG, motor (Unified Parkinson's Disease Rating Scale-motor: UPDRS III), neuropsychological (frontal, executive and memory tests) performance and mood were measured before (T(0)), after (T(1)) and 4-weeks after treatment (T(2)). A linear model with random effects and Wilcoxon test were used to detect differences. Main results include a reduction of beta rhythm in theta-tACS vs. RNS group at T(1) over right sensorimotor area (p = .014) and left parietal area (p = .010) and at T(2) over right sensorimotor area (p = .004) and left frontal area (p = .039). Bradykinesia items improved at T(1) (p = .002) and T(2) (p = .047) compared to T(0) in the tACS group. In the tACS group the Montréal Cognitive Assessment (MoCA) improved at T(2) compared with T(1) (p = .049). Individualized tACS in PD improves motor and cognitive performance. These changes are associated with a reduction of excessive fast EEG oscillations.